- World rank, 2022–2025
- #12,761 of 28,054
- Rank in ??
- #236 of 692
- Research works
- 80 ▲ 366% vs 2013–17
- Citations
- 822 10.3 per fractional work
- Top-10% rate
- 20.3% record average 16.5%
- Open access
- 70% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.
- Immunology and Microbiology 6.8×
- Biochemistry, Genetics and Molecular Biology 4.5×
- Medicine 2.5×
- Economics, Econometrics and Finance 2.0×
- Health Professions 1.6×
- Neuroscience 0.7×
- Nursing 0.5×
- Mathematics 0.5×
- Physics and Astronomy 0.5×
- Psychology 0.3×
- Dentistry 0.3×
- Business, Management and Accounting 0.2×
- Chemistry 0.2×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.2×
- Social Sciences 0.2×
- Engineering 0.1×
- Materials Science 0.1×
- Decision Sciences 0.1×
- Computer Science 0.1×
Which keywords describe research at Dartmouth Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Chemotherapy, Cancer, Cancer Therapy, Cancer Immunotherapy, Gene Expression and Targeted Therapy.
- Normalization
- Cell Death
- Antigen Presentation
- Data Analysis
- Prognostic Factors
- Cancer Treatment
- Primary Care
- Innate Immunity
- Lymphoma
- Tumor Regression
- Immunity
- Cell-Free DNA
- Genomic Instability
- Radiotherapy
- PD-1 and PD-L1
- Cancer Incidence
- Targeted Therapy
- Gene Expression
- Chemotherapy
- Cancer
- Immunotherapy
- Tumor Microenvironment
- Cancer Therapy
- Cancer Immunotherapy
- Quality of Life
- Immune Checkpoint Blockade
- Health Disparities
- Risk Factors
- Population-Based Study
- Global Surveillance
- Mortality Rates
- Cancer Genomics
- Mutational Signatures
- Precision Medicine
- CAR T Cells
- Chimeric Antigen Receptor
- Cost of Care
- Financial Toxicity
- Breast Cancer
- Neoadjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy5▲ 11×13 topics
- Cancer4▲ 5.3×22 topics
- Tumor Microenvironment4▲ 16×8 topics
- Chemotherapy4▲ 9.2×18 topics
- Cancer Therapy3▲ 7.6×7 topics
- Gene Expression3▲ 7.2×7 topics
- Cancer Immunotherapy3▲ 27×2 topics
- Targeted Therapy3▲ 18×4 topics
- Quality of Life2▲ 2.8×8 topics
- Cancer Incidence2▲ 27×4 topics
- Immune Checkpoint Blockade2▲ 35×1 topic
- PD-1 and PD-L12▲ 35×1 topic
- Health Disparities2▲ 14×4 topics
- Radiotherapy2▲ 9.5×10 topics
- Risk Factors2▲ 3.2×4 topics
- Genomic Instability2▲ 30×2 topics
- Population-Based Study2▲ 48×2 topics
- Cell-Free DNA2▲ 31×2 topics
- Global Surveillance2▲ 67×1 topic
- Immunity2▲ 7.4×6 topics
- Mortality Rates2▲ 32×1 topic
- Tumor Regression2▲ 27×2 topics
- Cancer Genomics2▲ 38×1 topic
- Lymphoma2▲ 18×2 topics
- Mutational Signatures2▲ 38×1 topic
- Innate Immunity2▲ 8.5×5 topics
- Precision Medicine2▲ 5.9×5 topics
- Primary Care2▲ 6.9×5 topics
- CAR T Cells2▲ 33×1 topic
- Cancer Treatment2▲ 10×5 topics
- Chimeric Antigen Receptor2▲ 33×1 topic
- Prognostic Factors2▲ 5.4×8 topics
- Cost of Care1▲ 74×1 topic
- Data Analysis1▲ 8.1×4 topics
- Financial Toxicity1▲ 74×1 topic
- Antigen Presentation1▲ 22×2 topics
- Breast Cancer1▲ 8.4×6 topics
- Cell Death1▲ 9.0×5 topics
- Neoadjuvant Therapy1▲ 9.1×5 topics
- Normalization1▲ 40×2 topics
Which research topics does Dartmouth Cancer Center publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Global Cancer Incidence and Screening, Cancer Genomics and Diagnostics and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 Global Cancer Incidence and Screening Oncology 2 works
- 3 Cancer Genomics and Diagnostics Cancer Research 2 works
- 4 CAR-T cell therapy research Oncology 2 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 6 Immunotherapy and Immune Responses Immunology 1 works
- 7 Immune Cell Function and Interaction Immunology 1 works
- 8 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 9 Pancreatic and Hepatic Oncology Research Oncology 1 works
- 10 Cancer survivorship and care Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dartmouth Cancer Center's research output changed?
Output in 2018–2022 was 366% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.